Physician profile
Walter J Lee
NPI 1821177460
$631.66
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $72.46 · 2021: $18.75.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $245.05 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $119.20 | 2019-2020 | |
| Astellas Pharma US INC | $77.80 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $39.72 | 2019 | |
| Allergan, INC. | $37.92 | 2019 | |
| Abbvie INC. | $18.75 | 2021 | |
| Amgen INC. | $18.08 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.96 | 2019 | |
| Amarin Pharma, INC. | $16.45 | 2019 | |
| Pfizer INC. | $14.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.81 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.